vs
Side-by-side financial comparison of NovoCure Ltd (NVCR) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.
NovoCure Ltd is the larger business by last-quarter revenue ($174.3M vs $124.7M, roughly 1.4× SMITH & WESSON BRANDS, INC.). SMITH & WESSON BRANDS, INC. runs the higher net margin — 1.5% vs -14.1%, a 15.6% gap on every dollar of revenue. On growth, NovoCure Ltd posted the faster year-over-year revenue change (8.1% vs -3.9%). SMITH & WESSON BRANDS, INC. produced more free cash flow last quarter ($16.3M vs $-22.9M). Over the past eight quarters, NovoCure Ltd's revenue compounded faster (12.2% CAGR vs -4.8%).
NovoCure Ltd is a global oncology company that develops and commercializes innovative Tumor Treating Fields (TTFields) therapy, a non-invasive wearable treatment using low-intensity electric fields to disrupt cancer cell division. Its approved therapies target glioblastoma, malignant mesothelioma and non-small cell lung cancer, serving patients across North America, Europe and Asia Pacific.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
NVCR vs SWBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $174.3M | $124.7M |
| Net Profit | $-24.5M | $1.9M |
| Gross Margin | 75.8% | 24.3% |
| Operating Margin | -23.2% | 3.3% |
| Net Margin | -14.1% | 1.5% |
| Revenue YoY | 8.1% | -3.9% |
| Net Profit YoY | 62.8% | -53.6% |
| EPS (diluted) | $-0.22 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $174.3M | $124.7M | ||
| Q3 25 | $167.2M | $85.1M | ||
| Q2 25 | $158.8M | $140.8M | ||
| Q1 25 | $155.0M | $115.9M | ||
| Q4 24 | $161.3M | $129.7M | ||
| Q3 24 | $155.1M | $88.3M | ||
| Q2 24 | $150.4M | $159.1M | ||
| Q1 24 | $138.5M | $137.5M |
| Q4 25 | $-24.5M | $1.9M | ||
| Q3 25 | $-37.3M | $-3.4M | ||
| Q2 25 | $-40.1M | $8.6M | ||
| Q1 25 | $-34.3M | $2.1M | ||
| Q4 24 | $-65.9M | $4.5M | ||
| Q3 24 | $-30.6M | $-1.9M | ||
| Q2 24 | $-33.4M | $27.9M | ||
| Q1 24 | $-38.8M | $7.9M |
| Q4 25 | 75.8% | 24.3% | ||
| Q3 25 | 73.2% | 25.9% | ||
| Q2 25 | 73.9% | 28.8% | ||
| Q1 25 | 75.1% | 24.1% | ||
| Q4 24 | 79.2% | 26.6% | ||
| Q3 24 | 77.2% | 27.4% | ||
| Q2 24 | 77.0% | 35.5% | ||
| Q1 24 | 75.7% | 28.7% |
| Q4 25 | -23.2% | 3.3% | ||
| Q3 25 | -21.5% | -3.5% | ||
| Q2 25 | -24.9% | 9.3% | ||
| Q1 25 | -24.4% | 4.1% | ||
| Q4 24 | -39.3% | 5.8% | ||
| Q3 24 | -20.7% | -1.7% | ||
| Q2 24 | -22.3% | 17.4% | ||
| Q1 24 | -30.0% | 8.2% |
| Q4 25 | -14.1% | 1.5% | ||
| Q3 25 | -22.3% | -4.0% | ||
| Q2 25 | -25.3% | 6.1% | ||
| Q1 25 | -22.1% | 1.8% | ||
| Q4 24 | -40.9% | 3.5% | ||
| Q3 24 | -19.7% | -2.1% | ||
| Q2 24 | -22.2% | 17.5% | ||
| Q1 24 | -28.0% | 5.7% |
| Q4 25 | $-0.22 | $0.04 | ||
| Q3 25 | $-0.33 | $-0.08 | ||
| Q2 25 | $-0.36 | $0.19 | ||
| Q1 25 | $-0.31 | $0.05 | ||
| Q4 24 | $-0.61 | $0.10 | ||
| Q3 24 | $-0.28 | $-0.04 | ||
| Q2 24 | $-0.31 | $0.60 | ||
| Q1 24 | $-0.36 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.5M | $22.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $340.5M | $363.2M |
| Total Assets | $804.3M | $548.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.5M | $22.4M | ||
| Q3 25 | $342.1M | $18.0M | ||
| Q2 25 | $149.6M | $25.2M | ||
| Q1 25 | $127.3M | $26.7M | ||
| Q4 24 | $163.8M | $39.1M | ||
| Q3 24 | $185.4M | $35.5M | ||
| Q2 24 | $164.8M | $60.8M | ||
| Q1 24 | $453.8M | $47.4M |
| Q4 25 | $340.5M | $363.2M | ||
| Q3 25 | $341.3M | $364.4M | ||
| Q2 25 | $349.4M | $372.5M | ||
| Q1 25 | $362.0M | $366.9M | ||
| Q4 24 | $360.2M | $371.5M | ||
| Q3 24 | $360.8M | $380.0M | ||
| Q2 24 | $361.8M | $399.9M | ||
| Q1 24 | $359.4M | $376.4M |
| Q4 25 | $804.3M | $548.6M | ||
| Q3 25 | $1.4B | $554.6M | ||
| Q2 25 | $1.2B | $559.6M | ||
| Q1 25 | $1.2B | $578.9M | ||
| Q4 24 | $1.2B | $587.4M | ||
| Q3 24 | $1.2B | $571.3M | ||
| Q2 24 | $1.2B | $577.4M | ||
| Q1 24 | $1.1B | $570.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.0M | $27.3M |
| Free Cash FlowOCF − Capex | $-22.9M | $16.3M |
| FCF MarginFCF / Revenue | -13.1% | 13.1% |
| Capex IntensityCapex / Revenue | 2.8% | 8.8% |
| Cash ConversionOCF / Net Profit | — | 14.22× |
| TTM Free Cash FlowTrailing 4 quarters | $-75.7M | $21.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.0M | $27.3M | ||
| Q3 25 | $20.6M | $-8.1M | ||
| Q2 25 | $-15.9M | $40.8M | ||
| Q1 25 | $-35.7M | $-9.8M | ||
| Q4 24 | $-3.5M | $-7.4M | ||
| Q3 24 | $10.4M | $-30.8M | ||
| Q2 24 | $-1.7M | $43.7M | ||
| Q1 24 | $-31.6M | $25.2M |
| Q4 25 | $-22.9M | $16.3M | ||
| Q3 25 | $14.9M | $-12.4M | ||
| Q2 25 | $-21.4M | $33.5M | ||
| Q1 25 | $-46.3M | $-16.1M | ||
| Q4 24 | $-12.4M | $-10.7M | ||
| Q3 24 | $-307.0K | $-35.5M | ||
| Q2 24 | $-13.2M | $38.2M | ||
| Q1 24 | $-43.4M | $7.0M |
| Q4 25 | -13.1% | 13.1% | ||
| Q3 25 | 8.9% | -14.6% | ||
| Q2 25 | -13.5% | 23.8% | ||
| Q1 25 | -29.9% | -13.9% | ||
| Q4 24 | -7.7% | -8.3% | ||
| Q3 24 | -0.2% | -40.2% | ||
| Q2 24 | -8.8% | 24.0% | ||
| Q1 24 | -31.3% | 5.1% |
| Q4 25 | 2.8% | 8.8% | ||
| Q3 25 | 3.4% | 5.0% | ||
| Q2 25 | 3.5% | 5.2% | ||
| Q1 25 | 6.8% | 5.4% | ||
| Q4 24 | 5.5% | 2.5% | ||
| Q3 24 | 6.9% | 5.3% | ||
| Q2 24 | 7.6% | 3.5% | ||
| Q1 24 | 8.5% | 13.2% |
| Q4 25 | — | 14.22× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.73× | ||
| Q1 25 | — | -4.68× | ||
| Q4 24 | — | -1.63× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | — | 3.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
